India to United States: Montelukast Export Trade Route

The India to United States Montelukast corridor is one of India's established pharmaceutical export routes, with 623 shipments documented worth a combined $87.4M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 70% of all export value, reflecting the consolidated nature of India's montelukast manufacturing sector.

Across 19 active suppliers, the average shipment value stands at $140.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with montelukast's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 12.4%, placing it at rank #1 among India's top montelukast export destinations globally.

On the import side, key buyers of Indian montelukast in United States include AMERISOURCE HEALTH SERVICES, MACLEODS PHARMA USA ,INC, AMERISOURCE HEALTH SERVICES DBA and 62 others. AMERISOURCE HEALTH SERVICES is the single largest importer with 43 shipments valued at $29.1M USD.

India's montelukast exports to United States are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 88 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, UNICHEM LABORATORIES LIMITED, HETERO LABS LIMITED — together account for 85% of total trade value on this route. The average shipment value of $140.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as montelukast sodium tablets 10mg bno. bmc92352a/bmc92354a md 10/23,ex.09/26 ps.1x500s and montelukast sodium 10mg tablets - ndc no.68001-0361-03 bn.bmc92355a mfg:10/23 exp:09/26, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AMERISOURCE HEALTH SERVICES is the largest importer with 43 shipments worth $29.1M USD — representing 33% of all montelukast imports from India on this route. A total of 65 buyers are active on this corridor.